You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Gilead Sciences, Inc. operates in multiple business segments primarily focused on pharmaceutical products. Major product lines include antiviral drugs for HIV/AIDS, liver diseases such as Hepatitis B and C, and drugs for inflammatory and respiratory diseases. They also have oncology and cell therapy divisions. |
Business Models for Each Product Line |
Gilead generates revenue through the sale of pharmaceutical products primarily to wholesalers, distributors, and healthcare institutions. HIV products constitute a significant portion of their sales. Major expenses include research and development for drug discovery, clinical trials, sales, marketing, and cost of goods sold including manufacturing expenses. |
Future Opportunities for Growth |
The company is focusing on expanding its oncology and cell therapy segments and exploring new therapeutic areas. They are also investing in developing treatments for unmet medical needs and new delivery mechanisms for existing drugs. Biotech innovation, strategic acquisitions, and partnerships are also opportunities for growth. |
Potential Major Risks |
Major risks include competition from generic drugs, regulatory challenges, and patent expirations. Additionally, the company's growth is heavily dependent on successful product development and commercialization, which involve high costs and inherent uncertainties. There is also significant exposure to pricing pressures from healthcare providers and government policies globally. |
Learn More about Gilead Sciences, Inc.:
Company Insights by Algobear (ChatGPT);
Tell me more about Gilead Sciences, Inc.'s latest earnings (GILD:Nasdaq)
Who are some of Gilead Sciences, Inc.'s competitors? (GILD:Nasdaq)
Are analysts bullish on Gilead Sciences, Inc.? Please show it in a table format. (GILD:Nasdaq)
Also read:
https://finance.yahoo.com/GILD/profile
Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | PEG Ratio (5yr expected) | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Quarterly Earnings Growth | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
130.32 B | 130320000000.0 | 130.32 | 145.47 B | 145470000000.0 | 145.47 | 275.11 | 13.24 | 0.22 | 4.56 | 6.74 | 5.06 | 32.81 | 1.67% | 33.07% | 11.03% | 2.29% | 28.75 B | 28750000000.0 | 28.75 | 6.40% | 13.45 B | 13450000000.0 | 13.45 | 0.38 | 24.80% | 11.57 B | 11570000000.0 | 11.57 | 27.32 B | 27320000000.0 | 27.32 | 1.4196 | 1.6 | 10.83 B | 10830000000.0 | 10.83 | 10.13 B | 10130000000.0 | 10.13 | 0.12% | 89.55% |
source:https://finance.yahoo.com/GILD/key-statistics
source:https://www.google.com/finance/quote/GILD:NASDAQ
source:https://finance.yahoo.com/GILD/analysis
source:https://finance.yahoo.com/GILD/fair-value
source:https://www.nasdaq.com/market-activity/stocks/GILD/price-earnings-peg-ratios
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 9.39% | 3.13% (107.56) | 10.02% (114.75) | 15.01% (119.96) | 15.01% (119.96) | 15.01% (119.96) | 15.01% (119.96) | 18.28% (123.37) |
Downside % (low) | 13.22% | 10.48% (93.37) | 10.48% (93.37) | 11.59% (92.21) | 17.93% (85.6) | 40.49% (62.07) | 45.19% (57.17) | 45.77% (56.56) |
Spread % | -3.83% | -7.35% | -0.46% | 3.42% | -2.91% | -25.47% | -30.17% | -27.49% |
GILD's price used for computing the stats is 104.3 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | -1.92% | -0.03% | 0.65% | -4.55% | 12.1% | 21.53% | 55.49% | 63.61% | -0.86% |
Last Price | 104.3 | 104.3 | 104.3 | 104.3 | 104.3 | 104.3 | 104.3 | 104.3 | 104.3 |
Trend-Previous Close | 106.34 | 104.33 | 103.63 | 109.27 | 93.04 | 85.82 | 67.08 | 63.75 | 105.2 |
GILD's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
returns:
-0.03%
(-2.06%),
p.close: 104.33
entry:
102.18,
exit:
102.48,
min.ret:
0.3%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.03%
(-3.58%),
p.close: 104.33
entry:
100.59,
exit:
102.98,
min.ret:
2.37%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.03%
(-7.02%),
p.close: 104.33
entry:
97.0,
exit:
97.57,
min.ret:
0.59%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.03%
(-5.45%),
p.close: 104.33
entry:
98.64,
exit:
98.7,
min.ret:
0.07%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.03%
(-4.99%),
p.close: 104.33
entry:
99.13,
exit:
99.15,
min.ret:
0.03%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
-0.03%
(-4.33%),
p.close: 104.33
entry:
99.82,
exit:
99.68,
min.ret:
-0.14%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
returns:
0.65%
(3.97%),
p.close: 103.63
entry:
107.75,
exit:
107.8,
min.ret:
-0.05%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.65%
(5.17%),
p.close: 103.63
entry:
108.99,
exit:
108.3,
min.ret:
0.63%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.65%
(11.14%),
p.close: 103.63
entry:
115.17,
exit:
115.93,
min.ret:
-0.66%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.65%
(9.85%),
p.close: 103.63
entry:
113.84,
exit:
113.53,
min.ret:
0.27%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.65%
(9.41%),
p.close: 103.63
entry:
113.39,
exit:
113.05,
min.ret:
0.3%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
returns:
-4.55%
(-11.68%),
p.close: 109.27
entry:
96.51,
exit:
97.78,
min.ret:
1.32%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-4.55%
(-9.12%),
p.close: 109.27
entry:
99.3,
exit:
99.02,
min.ret:
-0.29%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-4.55%
(-7.55%),
p.close: 109.27
entry:
101.02,
exit:
101.27,
min.ret:
0.25%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
BUY-APPROACHING
returns:
-4.55%
(-7.38%),
p.close: 109.27
entry:
101.21,
exit:
102.05,
min.ret:
0.83%
Using: 1M trend, 0 Days Left
|
GILD's symbol current price is 104.3 (-1.92%) as on . Yesterday's close was 106.34. It's return velocities are computed basis data from date .